Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Vivos Therapeutics (VVOS) Return on Assets (2021 - 2025)

Vivos Therapeutics has reported Return on Assets over the past 5 years, most recently at 0.01% for Q4 2025.

  • Quarterly Return on Assets changed 0.0% to 0.01% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.01% through Dec 2025, changed 0.0% year-over-year, with the annual reading at 0.01% for FY2025, 0.0% changed from the prior year.
  • Return on Assets was 0.01% for Q4 2025 at Vivos Therapeutics, down from 0.01% in the prior quarter.
  • Over five years, Return on Assets peaked at 0.01% in Q3 2023 and troughed at 0.01% in Q1 2024.
  • The 5-year median for Return on Assets is 0.01% (2021), against an average of 0.0%.
  • Year-over-year, Return on Assets rose 1bps in 2023 and then decreased -2bps in 2024.
  • A 5-year view of Return on Assets shows it stood at 0.0% in 2021, then soared by 1112bps to 0.0% in 2022, then tumbled by -21039bps to 0.01% in 2023, then soared by 44bps to 0.01% in 2024, then decreased by -15bps to 0.01% in 2025.
  • Per Business Quant, the three most recent readings for VVOS's Return on Assets are 0.01% (Q4 2025), 0.01% (Q3 2025), and 0.01% (Q2 2025).